Utilizing a Modality-Agnostic Platform for a Head-to-Head Comparison of mRNA & DNA-based Personalized Cancer Vaccines in Creating an Immune Response
Time: 1:30 pm
day: Conference Day One
Details:
- Comparing DNA and mRNA as modalities to encode for fusion proteins in individualized cancer vaccines to effectively induce an immune response
- Utilizing a unique bioinformatics platform to target immunogenic APCs in personalized cancer vaccines for better tumor control
- Exploring DNA-based personalized cancer vaccines that produce differentiated and more effective T-cells
